Medical Centrifuge Global Market Report 2024

The medical centrifuge market size has grown strongly in recent years. It will grow from $1.96 billion in 2023 to $2.09 billion in 2024 at a compound annual growth rate (CAGR) of 6.3%. The expansion observed in the historical period can be attributed to scientific advancements, growth in the healthcare industry, developments in biomedical research, evolution in clinical diagnostics, and improvements in safety standards within the medical field.

The medical centrifuge market size is expected to see strong growth in the next few years. It will grow to $2.71 billion in 2028 at a compound annual growth rate (CAGR) of 6.8%. The anticipated growth in the forecast period can be attributed to the rise in healthcare expenditure, the growth of point-of-care testing, increased demand for specialized centrifuges, expansion of digitalization and connectivity, and a focus on energy efficiency within the medical centrifuge industry. Major trends expected in the forecast period include the development of compact and portable designs, automation and integration in centrifuge systems, advancements in rotor technology, a focus on energy efficiency, and an overall commitment to sustainability in the industry.

The anticipated growth in the medical centrifuge market is driven by an increasing number of research and development activities. These activities play a crucial role in acquiring market knowledge before the development of new goods and services, particularly in the medical field. Centrifuges find widespread use in research and clinical facilities for purifying cells, organelles, viruses, proteins, and nucleic acids. An example is the Accelerating Access to Genomics for Global Health report from the World Health Organization (WHO) in July 2022, indicating a rise in the percentage of nations equipped for genomic surveillance from 54% to 68% due to increased investments during the COVID-19 pandemic. Consequently, the growing focus on research and development activities propels the medical centrifuge market.

The growth of the medical centrifuge market is further propelled by the increasing incidence of chronic diseases. Chronic diseases, characterized by long-term health conditions, necessitate the use of medical centrifuges in the diagnosis and management of these ailments. In September 2022, the World Health Organization reported that 74% of the 41 million deaths globally each year are caused by non-communicable diseases (NCDs) or chronic diseases. Cardiovascular diseases, cancer, chronic respiratory diseases, and diabetes contribute significantly to this statistic. The application of medical centrifuges in addressing chronic diseases underscores their importance in healthcare.

Product innovation emerges as a prominent trend in the medical centrifuge market, with major companies introducing advanced solutions to maintain their market standing. For instance, in April 2021, Eppendorf AG introduced the Centrifuge 5910 Ri, featuring an innovative touchscreen interface for efficient laboratory operations. The integration of new documentation options and enhanced security measures further contributes to improved functionality. Similarly, companies are focusing on developing advanced solutions such as DynaSpin technology, as seen in Thermo Fisher Scientific's launch of the DynaSpin Single-Use Centrifuge system in September 2022. This technology optimizes large-scale cell culture harvesting, reducing material requirements and waste, while maintaining or improving product yield.

Major players in the medical centrifuge market are directing their efforts toward the development of cutting-edge solutions, including DynaSpin technology, to optimize large-scale cell culture harvesting for bioprocessing. DynaSpin technology, a centrifugation innovation, is designed to streamline the harvest process by minimizing the need for depth filtration cartridges. In September 2022, Thermo Fisher Scientific, a prominent US-based biotechnology company, introduced the Thermo Scientific DynaSpin Single-Use Centrifuge system. This system aims to enhance the efficiency of large-scale cell culture harvesting by reducing the reliance on depth filtration cartridges, resulting in improved efficiency and maintained or enhanced product yield. Notably, this innovative approach leads to a substantial reduction in material requirements, cutting waste by 70% compared to conventional systems. The DynaSpin system is crafted to seamlessly integrate with the 5,000-liter Thermo Scientific DynaDrive Bioreactor. It places a strong emphasis on environmental considerations and performance, contributing to the global accessibility of therapeutics and vaccines. The DynaSpin system offers scalability, facilitates quick changeovers, reduces downtime, and minimizes contamination risks in workflow, featuring an ergonomic design for straightforward operation and maintenance.

In July 2022, a significant development in the medical centrifuge market occurred with the merger of Accumax, an India-based manufacturer and exporter of lab consumables and liquid handling equipment, with Neuation, an India-based laboratory manufacturer. Neuation specializes in clinical centrifuges tailored to the specific requirements of healthcare professionals. This strategic merger is designed to streamline operations, enabling the combined entity to offer a more extensive range of products and achieve cost savings in shipping. The collaboration between Accumax and Neuation positions them as key players in the medical centrifuge market, reinforcing their commitment to delivering high-quality laboratory solutions.

Major companies operating in the medical centrifuge market report are Aesthetic Group, Scilogex LLC, Drucker Diagnostics Inc., Sartorius AG, Qiagen N.V, Thermo Fisher Scientific Inc., Andreas Hettich GmbH & Co. KG, Danaher Corporation, Eppendorf AG, HERMLE Labortechnik GmbH, KUBOTA Corporation, NuAire Inc., Sigma Laborzentrifugen GmbH, Hitachi Koki Co. Ltd., Labnet International Inc., MSE UK Ltd., Neuation, REMI GROUP, Centurion Scientific Ltd., AccuBioTech Co. Ltd., Labocon, LaboGene ApS, Medline Scientific, MPW MED INSTRUMENTS, NuWind, Separation Technology Inc., SpInc.o Biotech Pvt. Ltd., Tharmac Biotech, Unico Inc., Zhermack SpA, ZIRBUS technology GmbH.

North America was the largest region in the medical centrifuge market in 2023. Asia-Pacific is expected to be the fastest-growing region in the medical centrifuge market report during the forecast period. The regions covered in the medical centrifuge market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the medical centrifuge market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The primary types of medical centrifuges include bench-top, floor-standing, tabletop, and portable models. A benchtop centrifuge is a compact, countertop-sized centrifuge designed for laboratory use, primarily employed to apply centrifugal force and separate elements in a liquid or solid mixture. The capacity of these centrifuges includes microcentrifuge, medium capacity centrifuge, and large capacity centrifuge, maintained at both refrigerated and non-refrigerated temperatures. They are utilized by hospitals, clinics, ambulatory surgical centers, and other medical facilities.

The medical centrifuge market research report is one of a series of new reports that provides medical centrifuge market statistics, including medical centrifuge industry global market size, regional shares, competitors with a medical centrifuge market share, detailed medical centrifuge market segments, market trends, and opportunities, and any further data you may need to thrive in the medical centrifuge industry. This medical centrifuge market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.


This product will be delivered within 3-5 business days.